Beckman Coulter Life Sciences and Illumina announced the launch of the Illumina TruSight Oncology 500 DNA/ RNA assay on the Biomek NGeniuS System from Beckman Coulter Life Sciences. The applications support both DNA and RNA inputs to enable the detection of cancer biomarkers. The companies claim complete library preparation can be achieved in less than three days. Four to 24 libraries can be processed in a single batch. The assay is also optimized for reduced plastic use and lower consumable costs. The new application joins the Illumina DNA Prep, DNA PCR-Free Prep, and RNA Prep with Enrichment applications, which are all available in a first-of-its-kind open chemistry, cloud-based Biomek NGeniuS System Applications Library.
Beckman Coulter Life Sciences
Illumina
